Zobrazeno 1 - 10
of 158
pro vyhledávání: '"Lois, Ayash"'
Autor:
Dipenkumar Modi, Samer Alkassis, Seongho Kim, Andrew Kin, Abhinav Deol, Lois Ayash, Voravit Ratanatharathorn, Joseph P. Uberti
Publikováno v:
Leukemia & Lymphoma. :1-10
Autor:
Asif Alavi, Voravit Ratanatharathorn, Seongho Kim, Harsh Shah, Andrew Kin, Hyejeong Jang, Jorgena Kosti, Paramveer Singh, Lois Ayash, Radhakrishnan Ramchandren, Joseph P. Uberti, Abhinav Deol
Publikováno v:
Leukemia & Lymphoma. 63:813-820
Utilization of novel agents such as brentuximab vedotin (BV) and check-point inhibitors (CI) has increased in patients with relapsed/refractory (r/r) classical Hodgkin Lymphoma (cHL). We conducted a retrospective study of 209 patients who had ASCT fo
Autor:
Seongho Kim, Abhinav Deol, Dipenkumar Modi, Lois Ayash, Joseph P. Uberti, Voravit Ratanatharathorn, Kyle Kondrat
Publikováno v:
Transplantation and Cellular Therapy. 27:760-767
Limited information is available on the efficacy of post-transplantation cyclophosphamide (PTcy) or thymoglobulin for graft-versus-host disease (GVHD) prophylaxis in mismatched unrelated donor (MMUD) transplants. We retrospectively compared outcomes
Autor:
Dipenkumar Modi, Maya Shatta, Seongho Kim, Abhinav Deol, Andrew Kin, Asif Alavi, Lois Ayash, Voravit Ratanatharathorn, Joseph P. Uberti
Publikováno v:
Blood. 140:694-695
Autor:
Abdul Moiz Khan, Neha Venkatesh, Joseph P. Uberti, Voravit Ratanatharathorn, Dipenkumar Modi, Lois Ayash, Asif Alavi, Andrew Kin, Aasiya Matin, Abhinav Deol
Publikováno v:
Blood. 140:7565-7566
Autor:
Voravit Ratanatharathorn, Dipenkumar Modi, Lois Ayash, Joseph P. Uberti, Abhinav Deol, Seongho Kim
Publikováno v:
Bone Marrow Transplantation. 56:741-744
Limited information is available on the impact of intensity of conditioning regimens in haploidentical peripheral blood stem cell transplant (haploPBSCT) with post-transplant cyclophosphamide (PTcy). We retrospectively compared outcomes of haplo-PBSC
Autor:
Abhinav Deol, Hyejeong Jang, Lois Ayash, Vijendra Singh, Voravit Ratanatharathorn, Seongho Kim, Asif Alavi, Joseph P. Uberti
Publikováno v:
Leukemia & Lymphoma. 62:446-453
The use of G-CSF post allogeneic transplant has become a common practice to accelerate neutrophil engraftment. There is some controversy in its use. To further evaluate the effectiveness, we compared outcomes in patients who underwent PBSCT, either w
Autor:
Malini Surapaneni, Abhinav Deol, Seongho Kim, Voravit Ratanatharathorn, Joseph P. Uberti, Dipenkumar Modi, Lois Ayash
Publikováno v:
Leukemia & Lymphoma. 61:3137-3145
Anti-thymocyte globulin (ATG) targets in-vivo T lymphocytes. Variations in the recipient absolute lymphocyte count (ALC) might result in a variable exposure of ATG. We hypothesized that recipient ALC on the first day of ATG might predict transplant o
Autor:
Jie Chi, Andrew Kin, Asif Alavi, Joseph P. Uberti, Abhinav Deol, Voravit Ratanatharathorn, Seongho Kim, Dipenkumar Modi, Lois Ayash
Publikováno v:
Leukemia & Lymphoma. 61:1877-1884
Maintenance therapy after first autologous transplant (autoSCT) improves progression-free survival (PFS) and overall survival (OS) in multiple myeloma (MM). However, efficacy of maintenance therapy after second autoSCT is unknown. We retrospectively
Autor:
Seongho Kim, Abhinav Deol, Dipenkumar Modi, Asif Alavi, Lois Ayash, Voravit Ratanatharathorn, Joseph P. Uberti, Malini Surapaneni
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:683-690
Allogeneic stem cell transplant (alloSCT) is considered in diffuse large B cell lymphoma (DLBCL) patients with chemorefractory disease or who have relapsed after autologous SCT. Here we present the first report of alloSCT using the R-BEAM (rituximab,